194 related articles for article (PubMed ID: 2562949)
1. Inhibition of antibody secretion by 5-aminosalicylic acid.
MacDermott RP; Schloemann SR; Bertovich MJ; Nash GS; Peters M; Stenson WF
Gastroenterology; 1989 Feb; 96(2 Pt 1):442-8. PubMed ID: 2562949
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
Comer SS; Jasin HE
J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
Neal TM; Winterbourn CC; Vissers MC
Biochem Pharmacol; 1987 Sep; 36(17):2765-8. PubMed ID: 2888463
[TBL] [Abstract][Full Text] [Related]
4. Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.
Goerg KJ; Wanitschke R; Gabbert H; Breiling J; Franke M; Meyer zum Büschenfelde KH
Digestion; 1987; 37(2):79-87. PubMed ID: 2887473
[TBL] [Abstract][Full Text] [Related]
5. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
Nielsen ST; Beninati L; Buonato CB
Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief report.
Andreasen JJ; Andersen LP; Hartzen SH
APMIS; 1988 Jun; 96(6):568-70. PubMed ID: 2899438
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Sheldon P; Pell P
Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
[No Abstract] [Full Text] [Related]
8. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
Kolassa N; Becker R; Wiener H
Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
[TBL] [Abstract][Full Text] [Related]
9. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
[TBL] [Abstract][Full Text] [Related]
10. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
Craven PA; Pfanstiel J; Saito R; DeRubertis FR
Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
[TBL] [Abstract][Full Text] [Related]
11. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
Symmons DP; Salmon M; Farr M; Bacon PA
J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients.
MacDermott RP; Kane MG; Steele LL; Stenson WF
Immunopharmacology; 1986 Apr; 11(2):101-9. PubMed ID: 2872186
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.
Shanahan F; Niederlehner A; MacDermott RP; Stenson WF; Kane MG; Targan S
Immunopharmacology; 1986 Apr; 11(2):111-8. PubMed ID: 2872187
[TBL] [Abstract][Full Text] [Related]
15. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA
J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
[TBL] [Abstract][Full Text] [Related]
18. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Hawkey CJ; Boughton-Smith NK; Whittle BJ
Dig Dis Sci; 1985 Dec; 30(12):1161-5. PubMed ID: 2866075
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostaglandin synthetase in human rectal mucosa.
Hawkey CJ; Lo Casto M
Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
